Get started
Author

Michael Kresken

The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
2020 · Matthias I. Gröschel, Conor J. Meehan, et al. · Nature Communications · 147
PDF
Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals
1997 · Wolfgang Witte, Michael Kresken, et al. · Clinical Microbiology and Infection · 125
Thirty years of VRE in Germany – “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci
2020 · Guido Werner, Bernd Neumann, et al. · Drug Resistance Updates · 116
PDF
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin
1988 · M Kresken, B Wiedemann · Antimicrobial Agents and Chemotherapy · 104
Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)
2012 · X. Schleicher, P.G. Higgins, et al. · Clinical Microbiology and Infection · 85
PDF
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii
2020 · Harald Seifert, Carina Müller, et al. · Journal of Antimicrobial Chemotherapy · 83
In Vitro Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
2011 · Will Stubbings, Pamela Leow, et al. · Antimicrobial Agents and Chemotherapy · 72
Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001
2004 · Michael Kresken, Dieter Hafner, et al. · International Journal of Antimicrobial Agents · 68
Antimicrobial Resistance and Type Distribution of Streptococcus pneumoniae Isolates Causing Systemic Infections in Germany, 1992-1994
1995 · R. R. Reinert, A. Queck, et al. · Clinical Infectious Diseases · 65
Nationwide German Multicenter Study on Prevalence of Antibiotic Resistance in Staphylococcal Bloodstream Isolates and Comparative In Vitro Activities of Quinupristin-Dalfopristin
2000 · Christof von Eiff, Ralf René Reinert, et al. · Journal of Clinical Microbiology · 64
Prevalence of fluoroquinolone resistance in Europe
1994 · the Study Group ‘Bacterial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy e. V., M. Kresken, et al. · Infection · 63
In Vitro Activity of Nitroxoline against Escherichia coli Urine Isolates from Outpatient Departments in Germany
2014 · Michael Kresken, Barbara Körber-Irrgang · Antimicrobial Agents and Chemotherapy · 62
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries
2015 · M. Kresken, B. Körber-Irrgang, et al. · Clinical Microbiology and Infection · 61
PDF
The epidemiology of -lactamases
1989 · B. Wiedemann, C. Kliebe, et al. · Journal of Antimicrobial Chemotherapy · 61
Urinary Concentrations and Antibacterial Activities of Nitroxoline at 250 Milligrams versus Trimethoprim at 200 Milligrams against Uropathogens in Healthy Volunteers
2013 · Florian M. E. Wagenlehner, Fabian Münch, et al. · Antimicrobial Agents and Chemotherapy · 60
Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: Extended-spectrum β-lactamases and the role of fosfomycin
2014 · Michael Kresken, Yvonne Pfeifer, et al. · International Journal of Antimicrobial Agents · 48
Activities of various β-lactams and β-lactam/β-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains
2005 · J. Brauers, U. Frank, et al. · Clinical Microbiology and Infection · 43
Changing Pattern of Antibiotic Resistance in Methicillin-ResistantStaphylococcus aureusFrom German Hospitals
2001 · Wolfgang Witte, Christine Braulke, et al. · Infection Control and Hospital Epidemiology · 40
Presence of hypervirulence-associated determinants in Klebsiella pneumoniae from hospitalised patients in Germany
2024 · Anika Wahl, Martin A. Fischer, et al. · International Journal of Medical Microbiology · 38
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany
2020 · Michael Kresken, Barbara Körber-Irrgang, et al. · International Journal of Antimicrobial Agents · 36
Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa* Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft "Resistenz" in der Paul-Ehrlich- Gesellschaft für Chemotherapie e. V. aus dem Jahre 1998 Originalarbeit
2000 · Michael Kresken, D. Häfner · 34
Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany
2011 · Study Group, M. Kresken, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 32
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany
2017 · Harald Seifert, Barbara Körber-Irrgang, et al. · International Journal of Antimicrobial Agents · 30
Surveillance of linezolid resistance in Germany, 2001–2002
2005 · J. Brauers, M. Kresken, et al. · Clinical Microbiology and Infection · 28
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates
2023 · Harald Seifert, Carina Müller, et al. · Antibiotics · 27
PDF
Works count: 150
Citation count: 2,325
H-index: 26
I10-index: 57
Year
Topic
Type